Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Jan 15;101(2):497–502. doi: 10.1172/JCI1101

Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients.

S A Spector 1, R Wong 1, K Hsia 1, M Pilcher 1, M J Stempien 1
PMCID: PMC508590  PMID: 9435323

Abstract

In this study, baseline plasma from 619 persons with acquired immunodeficiency syndrome (AIDS) (median CD4+ lymphocyte count -21/microl) who participated in a trial to determine the efficacy of oral ganciclovir for cytomegalovirus (CMV) disease prevention were evaluated for CMV DNA load by qualitative and quantitative polymerase chain reaction (PCR), and correlated with the development of CMV disease and survival. For participants without detectable plasma CMV DNA, the 12-mo Kaplan-Meier CMV disease event rate was 14% and 1% for the placebo and ganciclovir groups, respectively (P < 0.001). For PCR positive participants, CMV disease developed in 43% of placebo and 26% ganciclovir recipients (P < 0.017). Among placebo recipients, CMV PCR positivity was associated with a 3.4-fold increased risk of developing CMV disease (P < 0.001) whereas CD4+ lymphocyte count was not a useful predictor (P = 0.47). A positive plasma CMV DNA PCR was also associated with a 2.5-fold increased risk of death. Each log10 increase in baseline CMV DNA load was associated with a 3.1-fold increase in CMV disease (P < 0.001) and a 2.2-fold increase in mortality (P < 0.001). These data indicate that the risk of developing CMV disease and death in persons with advanced AIDS is directly related to the quantity of CMV DNA in plasma, and is a better predictor than CD4+ lymphocyte count in this population.

Full Text

The Full Text of this article is available as a PDF (187.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aspin M. M., Gallez-Hawkins G. M., Giugni T. D., Tegtmeier B., Lang D. J., Schmidt G. M., Forman S. J., Zaia J. A. Comparison of plasma PCR and bronchoalveolar lavage fluid culture for detection of cytomegalovirus infection in adult bone marrow transplant recipients. J Clin Microbiol. 1994 Sep;32(9):2266–2269. doi: 10.1128/jcm.32.9.2266-2269.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bloom J. N., Palestine A. G. The diagnosis of cytomegalovirus retinitis. Ann Intern Med. 1988 Dec 15;109(12):963–969. doi: 10.7326/0003-4819-109-12-963. [DOI] [PubMed] [Google Scholar]
  3. Boom R., Sol C. J., Salimans M. M., Jansen C. L., Wertheim-van Dillen P. M., van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol. 1990 Mar;28(3):495–503. doi: 10.1128/jcm.28.3.495-503.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bowen E. F., Wilson P., Cope A., Sabin C., Griffiths P., Davey C., Johnson M., Emery V. Cytomegalovirus retinitis in AIDS patients: influence of cytomegaloviral load on response to ganciclovir, time to recurrence and survival. AIDS. 1996 Nov;10(13):1515–1520. doi: 10.1097/00002030-199611000-00009. [DOI] [PubMed] [Google Scholar]
  5. Crumpacker C. S. Ganciclovir. N Engl J Med. 1996 Sep 5;335(10):721–729. doi: 10.1056/NEJM199609053351007. [DOI] [PubMed] [Google Scholar]
  6. Detels R., Leach C. T., Hennessey K., Liu Z., Visscher B. R., Cherry J. D., Giorgi J. V. Persistent cytomegalovirus infection of semen increases risk of AIDS. J Infect Dis. 1994 Apr;169(4):766–768. doi: 10.1093/infdis/169.4.766. [DOI] [PubMed] [Google Scholar]
  7. Dodt K. K., Jacobsen P. H., Hofmann B., Meyer C., Kolmos H. J., Skinhøj P., Norrild B., Mathiesen L. Development of cytomegalovirus (CMV) disease may be predicted in HIV-infected patients by CMV polymerase chain reaction and the antigenemia test. AIDS. 1997 Mar;11(3):F21–F28. doi: 10.1097/00002030-199703110-00001. [DOI] [PubMed] [Google Scholar]
  8. Drew W. L. Cytomegalovirus infection in patients with AIDS. Clin Infect Dis. 1992 Feb;14(2):608–615. doi: 10.1093/clinids/14.2.608-a. [DOI] [PubMed] [Google Scholar]
  9. Frenkel L. D., Gaur S., Tsolia M., Scudder R., Howell R., Kesarwala H. Cytomegalovirus infection in children with AIDS. Rev Infect Dis. 1990 Sep-Oct;12 (Suppl 7):S820–S826. doi: 10.1093/clinids/12.supplement_7.s820. [DOI] [PubMed] [Google Scholar]
  10. Gerna G., Baldanti F., Zavattoni M., Sarasini A., Percivalle E., Revello M. G. Monitoring of ganciclovir sensitivity of multiple human cytomegalovirus strains coinfecting blood of an AIDS patient by an immediate-early antigen plaque assay. Antiviral Res. 1992 Oct 1;19(4):333–345. doi: 10.1016/0166-3542(92)90014-v. [DOI] [PubMed] [Google Scholar]
  11. Lalezari J. P., Stagg R. J., Kuppermann B. D., Holland G. N., Kramer F., Ives D. V., Youle M., Robinson M. R., Drew W. L., Jaffe H. S. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial. Ann Intern Med. 1997 Feb 15;126(4):257–263. doi: 10.7326/0003-4819-126-4-199702150-00001. [DOI] [PubMed] [Google Scholar]
  12. Mellors J. W., Rinaldo C. R., Jr, Gupta P., White R. M., Todd J. A., Kingsley L. A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996 May 24;272(5265):1167–1170. doi: 10.1126/science.272.5265.1167. [DOI] [PubMed] [Google Scholar]
  13. Palestine A. G., Polis M. A., De Smet M. D., Baird B. F., Falloon J., Kovacs J. A., Davey R. T., Zurlo J. J., Zunich K. M., Davis M. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med. 1991 Nov 1;115(9):665–673. doi: 10.7326/0003-4819-115-9-665. [DOI] [PubMed] [Google Scholar]
  14. Rasmussen L., Morris S., Zipeto D., Fessel J., Wolitz R., Dowling A., Merigan T. C. Quantitation of human cytomegalovirus DNA from peripheral blood cells of human immunodeficiency virus-infected patients could predict cytomegalovirus retinitis. J Infect Dis. 1995 Jan;171(1):177–182. doi: 10.1093/infdis/171.1.177. [DOI] [PubMed] [Google Scholar]
  15. Saltzman R. L., Quirk M. R., Jordan M. C. High levels of circulating cytomegalovirus DNA reflect visceral organ disease in viremic immunosuppressed patients other than marrow recipients. J Clin Invest. 1992 Nov;90(5):1832–1838. doi: 10.1172/JCI116059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Shinkai M., Bozzette S. A., Powderly W., Frame P., Spector S. A. Utility of urine and leukocyte cultures and plasma DNA polymerase chain reaction for identification of AIDS patients at risk for developing human cytomegalovirus disease. J Infect Dis. 1997 Feb;175(2):302–308. doi: 10.1093/infdis/175.2.302. [DOI] [PubMed] [Google Scholar]
  17. Shinkai M., Spector S. A. Quantitation of human cytomegalovirus (HCMV) DNA in cerebrospinal fluid by competitive PCR in AIDS patients with different HCMV central nervous system diseases. Scand J Infect Dis. 1995;27(6):559–561. doi: 10.3109/00365549509047067. [DOI] [PubMed] [Google Scholar]
  18. Spector S. A., McKinley G. F., Lalezari J. P., Samo T., Andruczk R., Follansbee S., Sparti P. D., Havlir D. V., Simpson G., Buhles W. Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group. N Engl J Med. 1996 Jun 6;334(23):1491–1497. doi: 10.1056/NEJM199606063342302. [DOI] [PubMed] [Google Scholar]
  19. Spector S. A., Merrill R., Wolf D., Dankner W. M. Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification. J Clin Microbiol. 1992 Sep;30(9):2359–2365. doi: 10.1128/jcm.30.9.2359-2365.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Webster A., Phillips A. N., Lee C. A., Janossy G., Kernoff P. B., Griffiths P. D. Cytomegalovirus (CMV) infection, CD4+ lymphocyte counts and the development of AIDS in HIV-1-infected haemophiliac patients. Clin Exp Immunol. 1992 Apr;88(1):6–9. doi: 10.1111/j.1365-2249.1992.tb03030.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES